MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Clinical trials for MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE explained in plain language.

Never miss a new study

Get alerted when new MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE trials appear

Sign up with your email to follow new studies for MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental pills target root cause of devastating muscle disease

Disease control Ongoing

This study is testing whether two oral supplements (deoxythymidine and deoxycytidine) can help people with a rare genetic disorder called TK2 deficiency. TK2 deficiency causes severe muscle weakness by preventing the body from making enough cellular energy. Researchers hope these…

Matched conditions: MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE

Get alerted when new MITOCHONDRIAL DNA DEPLETION SYNDROME 2 MYOPATHIC TYPE trials appear

Experimental pills target root cause of devastating muscle disease